Trials / Completed
CompletedNCT05466721
Evaluate Safety and Efficacy of Innovative Medical Devices for Colostomy Patients
HydrustomaC3 - Randomized Clinical Trial to Evaluate Safety and Efficacy of Innovative Medical Devices for Colostomy Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Hydrumedical · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
The surgical ostomy process happens when it is necessary to open an organ (such as the intestine) in order to maintain a communication channel with the external environment. The need for ostomy surgery can happen as a result of illness, genetic factors, or trauma. Despite the extensive improvements in colorectal surgery, in case there is a need for total or partial extraction and exteriorization of the large intestine (colostomy), it is often necessary to perform a stoma that connects the end of the preserved intestine to the skin, in which cases it is necessary to place a a colostomy bag for stool collection. Thus, there is a substantial number of patients who need to live with a permanent abdominal stoma that significantly affects their quality of life, implying significant changes, both physical and social. It will then be necessary for patients to adjust their daily routines in order to deal with stoma care. The primary objective of this study is to evaluate the Hydrustoma C3 medical devices (plate C3, capsule C3, night bag C3) in terms of its efficacy and safety as colostomy devices. It is also a primary objective of this study to compare the health-related quality of life in patients with colostomy when using a control and Hydrustoma C3 devices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hydrustoma C3 | The participant will use the device for 14 days. |
| DEVICE | Coloplast Alterna | The participant will use the device for 14 days. |
Timeline
- Start date
- 2022-06-13
- Primary completion
- 2023-12-19
- Completion
- 2023-12-31
- First posted
- 2022-07-20
- Last updated
- 2024-01-18
Locations
6 sites across 1 country: Portugal
Source: ClinicalTrials.gov record NCT05466721. Inclusion in this directory is not an endorsement.